The effect of an inhibitor of pulmonary inflammation in patients with Covid-19 : Evaluation of the efficacy and safety of pharmacological inhibition of bradykinin for the treatment of Covid-19

Medienart:

Klinische Studie

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

WHO International Clinical Trials Registry Platform - (2023) vom: 29. Mai Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: Coronavirus pneumonia;B97.2
Phase: Phase 2/Phase 3
Recruitment Status: Recruiting
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 05-05-2020, Last updated: 2023-06-05

ICTRP ID:

RBR-5s2mqg

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO006957927